feedback welcome

Haloperidol

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[draft revision][checked revision]
(Undo revision 5692 by Musys (talk))
 
(4 intermediate revisions not shown)
Line 16: Line 16:
| avail = 60-70
| avail = 60-70
| avail_ref = <ref name="informatorium">{{KNMP|haloperidol}}</ref>
| avail_ref = <ref name="informatorium">{{KNMP|haloperidol}}</ref>
-
| halflife = 12-38
+
| halflife = 17.5
-
| halflife_ref = <ref name="informatorium" />
+
| halflife_ref = <ref name="pts">{{pts|3791}}</ref><ref name="informatorium" />
-
| ct = 6.5
+
| administration = O,IM,IV
-
| ct_ref = <ref>{{pts}}</ref>
+
-
| administration = O, IM, IV
+
| dose = 0.25-15
| dose = 0.25-15
| dose_ref = <ref name="informatorium" />
| dose_ref = <ref name="informatorium" />
| DDD = 8
| DDD = 8
-
| DDD_ref = {{WHO|N05AD01}}
+
| DDD_ref = <ref>{{WHOCC|N05AD01}}</ref>
| ctox = 20
| ctox = 20
| ctox_ref = {{FTK-AP}}
| ctox_ref = {{FTK-AP}}
 +
| cth = 5
 +
| cth_ref = <ref name="pts" />
| <includeonly> isswitch=1</includeonly>
| <includeonly> isswitch=1</includeonly>
}}
}}

Current revision as of 09:58, 27 April 2010

Haloperidol
Type Antipsychotic
Group Butyrophenones
links
ATC-code N05AD01
Medscape Haloperidol
PubChem 3559
PubMed Haloperidol
Drugs.com haloperidol
Kompas (Dutch) Haloperidol
Wikipedia Haloperidol

Haloperidol is a Antipsychotic in the group Butyrophenones.



Navigation
About